Log In
Print this Print this

recAP (recombinant alkaline phosphatase) oral

  Manage Alerts
Collapse Summary General Information
Company AM-Pharma B.V.
DescriptionOral recombinant human alkaline phosphatase
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today